Bioventus Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Bioventus Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Bioventus Inc. Income Tax Expense (Benefit) for the quarter ending June 29, 2024 was -$7.34M, a 2026% decline year-over-year.
  • Bioventus Inc. Income Tax Expense (Benefit) for the twelve months ending June 29, 2024 was -$6.58M, a 83.6% increase year-over-year.
  • Bioventus Inc. annual Income Tax Expense (Benefit) for 2023 was $85K.
  • Bioventus Inc. annual Income Tax Expense (Benefit) for 2022 was -$44.4M, a 2157% decline from 2021.
  • Bioventus Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.97M, a 265% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $85K +$44.5M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$44.4M -$42.4M -2157% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 -$1.97M -$3.16M -265% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 $1.19M -$384K -24.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $1.58M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.